Frankfurt - Delayed Quote EUR

Lipigon Pharmaceuticals AB (publ) (9RP.F)

0.0038
0.0000
(0.00%)
At close: May 23 at 8:11:36 AM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,287
10,287
16,407
0
3,180
Operating Expense
35,864
35,864
28,779
37,742
44,371
Operating Income
-25,577
-25,577
-12,372
-37,742
-41,191
Net Non Operating Interest Income Expense
311
311
243
37
78
Pretax Income
-25,264
-25,264
-12,128
-37,705
-41,113
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-25,264
-25,264
-12,128
-37,705
-41,113
Diluted NI Available to Com Stockholders
-25,264
-25,264
-12,128
-37,705
-41,113
Basic EPS
-0.18
-0.14
-0.15
-1.63
-2.57
Diluted EPS
-0.18
-0.14
-0.15
-1.63
-2.57
Basic Average Shares
140,425.6480
180,349.2930
83,549.8200
23,181.2720
15,989.2500
Diluted Average Shares
140,425.6480
202,192.3820
208,486.3310
23,181.2720
15,989.2500
Total Operating Income as Reported
-25,576
-25,576
-12,371
-37,742
-41,191
Total Expenses
35,864
35,864
28,779
37,742
44,371
Net Income from Continuing & Discontinued Operation
-25,264
-25,264
-12,128
-37,705
-41,113
Normalized Income
-25,264
-25,264
-12,128
-37,705
-41,113
Interest Income
382
382
246
37
83
Interest Expense
71
71
3
0
5
Net Interest Income
311
311
243
37
78
EBIT
-25,193
-25,193
-12,125
-37,705
-41,108
EBITDA
-25,134
-25,134
-12,101
-37,681
-41,085
Reconciled Depreciation
59
59
24
24
23
Net Income from Continuing Operation Net Minority Interest
-25,264
-25,264
-12,128
-37,705
-41,113
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-25,134
-25,134
-12,101
-37,681
-41,085
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/3/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

9F1.F Diagonal Bio AB (publ)
0.0002
0.00%
 
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
 
NANECH.ST NanoEcho AB
0.1034
+0.39%
 
ISOFOL.ST Isofol Medical AB (publ)
1.1470
-4.34%
 
ACTI.ST Active Biotech AB (publ)
0.2410
+53.90%
 
ONCO.ST Oncopeptides AB (publ)
1.9960
+1.32%
 
STTK Shattuck Labs, Inc.
1.0800
+8.00%
 
ETNB 89bio, Inc.
9.49
-1.66%
 
MDGL Madrigal Pharmaceuticals, Inc.
267.56
-2.12%
 
ALT Altimmune, Inc.
5.71
-1.04%